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Introduction
The growing market of animal health products may account 
for the potential revenue source of companion animal care. 
The animal health care has resulted in more than one billion 
sales in 2007 for Novartis, Pfizer and Heska (Kling 2007). 
The opportunity to carry out preclinical trials based on spon-
taneous tumors has been considered suitable to develop new 
effective drugs that could be quickly translated into clinical 
practice (De Vico et al. 2005; Porrello et al. 2006; Vail and 
MacEwen 2000). For instance, naturally occurring tumors 
in dogs share similarities with human cancer both in terms 
of histopathological features and biological behavior (Hahn 
et al. 1994). In the second half of the 1800s, a substantial 
parallel between the animal and human oncopathology had 
already been observed (Porrello et al. 2006). In 1937, evi-
dence showed that spontaneous animal tumors were similar 
to their human counterpart and information retrieved from 
them might have clinical implications (Dobberstein 1937). 
In the early 1970s, the first World Health Organization 
(WHO) International Histological Classification of Tumors 
of Domestic Animals was published (Beveridge and Sobin 
1974, 1976). It was followed by the TNM Classification of 
Tumors in Domestic Animals based on the guidelines of the 
TNM Classification of Malignant Tumors in Man (Owen 
1980) showing that spontaneous canine and feline tumors 
are relevant models to study human cancers. We summa-
rized such models in Table 1 according to the review from 
De Vico et al. (2005). Conversely, in vivo and in vitro mod-
els, based on rodents and cell lines, have displayed intrinsic 
limits, such as complexity of management (Schiffer 1997) 
and the experimental methods used to induce the pathol-
ogy (Vail and Thamm 2004), which make them different 
from the human spontaneous diseases (De Vico et al. 2005; 
Moore and Siopes 2004).
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Searching criteria
We searched PubMed/MEDLINE using the keywords 
“spontaneous”, “animal”, “tumor”, “oncology” and “com-
parative” alone or in combination and cross-referencing 
among published papers. Selected papers from 1910 to 
2013 were chosen on the basis of their content (evidence-
based quality and reliability).
Epidemiology of cancer in dogs
Spontaneous canine tumors, such as prostate carcinoma, 
chondrosarcoma, which accounts for approximately 10 % 
of all primary bone tumors in dogs (Beveridge and Sobin 
1976), axial osteosarcoma, which accounts for 80 % of all 
primary bone tumors in dogs (Thompson and Pool 2002) 
and synovial cell sarcoma, have been extensively described 
Table 1  Summary of tumor features shared between animals and humans (Allen et al. 2002)
Model Kind of tumor Features
Canine/Feline Non-Hodgkin’s lymphoma Equates to intermediate and high-grade non-Hodgkin’s lymphoma in humans
Immune system alterations seem to be associated with a higher incidence of  
non-Hodgkin’s lymphoma
Is very sensitive to chemotherapy
Currently used as a model for testing new chemotherapeutics and new forms of immunother-
apy, as well as for the study of multiple drug resistance; it has been used as a relevant model 
for (1) developing hypoxic cell markers, (2) studying the effect of whole-body hyperther-
mia on the pharmacokinetics of systemic chemotherapy and (3) studying autologous bone 
transplantation
Canine Soft tissue sarcomas Similar to pathological appearance, clinical presentation and behavior of human soft tissue 
sarcomas
Respond to radiation therapy and chemotherapy in a manner similar to human pathology
Hemangiosarcomas are extremely similar to human hemangiosarcomas with respect to histo-
logical pattern and metastatic behavior
Canine Osteosarcomas Similar to human osteosarcomas with respect to the histology, metastatic behavior and clini-
cal evolution of the disease
Canine Oral malignant melanomas They are chemoresistant and share many immunological targets with human oral  
malignant melanomas
Considered a relevant model for developing new immunotherapeutic approaches for both 
dogs and humans
Both in dogs and humans, human tyrosinase DNA vaccination is safe and potentially effective
Canine Transitional cell carcinomas Share histological appearance, biological behavior and response to therapy with invasive 
human transitional cell carcinomas
Considered a useful model for testing new photodynamic therapy technologies and  
chemotherapeutic combinations
Canine Mast cell tumors Mutation of exon 11 of c-kit occurs in 30–50 % of advanced mast cell tumors and is  
similar to that usually occurring in 50–90 % of human gastrointestinal stromal tumors
Canine/Feline Mammary carcinomas Very similar to human breast cancers because of their hormonal dependence, spontaneous 
development in middle-aged to older animals, metastatic behavior toward regional lymph 
nodes and lungs, as well as adhesion molecules and neoangiogenesis patterns
Abnormalities in the nuclear DNA content have been documented in both malignant and 
benign canine mammary tumors, but are more frequent in human mammary carcinomas
Mammary neoplasia in dogs may be a good molecular model for developing new antineo-
plastic strategies involving cyclin D1 and cyclin-dependent kinases
Feline mammary carcinoma shows age incidence, histopathology and pattern of metastasis 
similar to human breast cancer
Feline mammary carcinoma shares common features with human inflammatory mammary 
carcinoma and human mammary carcinoma with osteoclast-like giant cells
Epidermal growth factor receptor-2 (HER-2) and recepteur d’origine nantais (RON) overex-
pressions qualify feline mammary carcinoma as homologous to human breast carcinomas 
which have poor prognosis
Canine Seminomas Metastases occur only in a small percentage of cases, whereas human seminomas have a 
marked tendency to metastasize
Have a histogenetic behavior similar to that of human seminomas
Canine Transmissible venereal tumor Is considered a promising model to study human Kaposi’s sarcoma
Percutaneous inoculation and intraarterial transplantation of tumor fragments in the canine 
lung result in predictable patterns of tumor growth resembling the solitary pulmonary  
nodules and metastatic disease found in humans
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representing valuable models to study carcinogenesis (Vail 
et al. 1994). Most canine prostate carcinomas affect both 
elderly sexually intact dogs and dogs which had under-
gone surgical castration after reaching sexual maturity. In 
2005–2009, a pilot study evaluated the incidence of spon-
taneous tumors in dogs living in the neighborhood of Ven-
ice and Vicenza (Vascellari et al. 2009). Two thousand five 
hundred and nine out of 296,318 canine cases of neopla-
sia were diagnosed during the first three years. The esti-
mated annual tumor incidence rate per 100,000 dogs was 
282, with an equal distribution of malignant and benign 
tumors between male and female dogs. Moreover, in pure 
breeds, a twofold higher incidence of malignant tumors, 
with respect to mixed breeds, was observed. The incidence 
increased with age in both genders. Due to the dissimilar 
methodologies and variable reference populations of both 
European and North American veterinary cancer registries, 
the occurrence of spontaneous tumors in pet animals has 
been underestimated (Bonnett et al. 1997; Dobson et al. 
2002; Dorn et al. 1968; Parkin and Muir 1992; Priester 
and McKay 1980). The Animal Tumor Registry of Genoa 
(Italy) retrospectively showed that, from 1985 to 2002, 
70 % of all cancer cases in female dogs were located in the 
breast (Merlo et al. 2008). The overall incidence of cancer 
was 99.3 per 100,000 dogs per year in male dogs and 272.1 
in female dogs. Among domestic animal tumors, spontane-
ous squamous cell carcinomas provided additional infor-
mation about the pathology of oral cancer (Gardner 1996). 
As far as oral tumors affecting dogs are concerned, malig-
nant melanoma accounts for the 4 % of all canine tumors 
(MacEwen et al. 1999). Canine malignant melanomas and 
human melanomas are treated similarly using surgery and/
or fractionated radiation therapy and immunological thera-
pies (Vail and Thamm 2004; Bergman et al. 2003). There-
fore, canine malignant melanomas are suitable models for 
new immunotherapeutic protocols in humans (Vail and 
Thamm 2004). Dogs and cats also frequently develop squa-
mous cell carcinomas (Dorn and Priester 1976; Strafuss 
et al. 1976). Skin and subcutaneous tissue neoplasms are 
the most frequently recognized neoplastic disorders in 
domestic animals and can be caused by prolonged and con-
tinuous exposure to sunlight (Madewell 1981). Alimentary 
tract cancer in dogs has lower incidence, with ductal and 
acinar carcinomas occurring most frequently in females 
than in males while intranasal tumors account for 1–2 % 
of all canine neoplasms (Priester 1974). Primary bone can-
cer is the second most often detected in dogs, and its main 
risk factors are ionizing radiations, chemical carcinogens 
and viruses (Madewell 1981). Moreover, preexisting bone 
defects and skeletal abnormalities increase the risk factors 
from 60 up to 185 times for large and giant breeds with 
respect to small dogs (Tjalma 1966). As to primary brain 
tumors, they account for approximately 2 % of all cancer 
in human adults (McKinney 2004) and for 0.01 % in dogs 
(LeCouteur 1999). Specifically, gliomas are more common 
among brachycephalic breeds of dogs, especially boxers, 
English bulldogs and Boston terriers (Hayes 1976). High 
incidence rates were also detected for non-Hodgkin’s lym-
phoma in bitches and for non-Hodgkin’s lymphoma and 
skin cancer in male dogs (Merlo et al. 2008). Additionally, 
the incidence rate of cancer increased with age ranging 
between 23.7 and 763.2 in bitches and 16.5 and 237.6 in 
male dogs aged ≤3 and >9–11 years. Hemangiosarcoma, 
which can affect both cats and dogs, involves the muscu-
loskeletal system, and mean survival time in dogs affected 
by this condition ranges from 267 (Ogilvie et al. 1996) 
to 780 days (Ward et al. 1994), depending on the disease 
stage. The ovarian and epithelial tumors, although quite 
rare in domestic animals, have been reported mainly in 
cats, dogs and horses (MacLachlan 1987). A single unique 
gonadoblastoma tumor affecting human males or females 
has been observed in the testicle of a dog (Turk et al. 1981). 
Spontaneous testicular tumors, which are quite common in 
aged dogs, are mainly seminomas (solitary, unilateral, more 
frequent in the right testicle and with a reduced possibility 
to develop metastases, if compared with humans) (Kennedy 
et al. 1998), Sertoli cell tumors and Leydig cell tumors, 
which can coexist together along with seminomas (Nielsen 
and Kennedy 1990) and occur with the same frequency 
(Maiolino et al. 2004). Maiolino et al. suggested a possible 
correspondence between human spermatocytic seminomas 
and most canine seminomas in order to justify their low 
metastatic behavior, showing a potential predictive model 
for the development of a treatment protocol (Maiolino et al. 
2004). Further, rare dog tumors are fibrosarcoma, rib, ver-
tebral body and pelvis tumors (both in dogs and in cats) 
(Dernell et al. 1998; Pirkey-Ehrhart et al. 1995; Straw et al. 
1992) and multiple myeloma (rare in cats and uncommon 
in dogs), which accounts for 8 % of all canine hematopoi-
etic tumors and affects older dogs with no breed or sex 
predilection (Matus et al. 1986) and intracranial central 
neurocytomas (Russell and Burch 1959). Canine mast cell 
tumors, which account for 16–21 % in this species (Thamm 
and Vail 2001), display a molecular alteration in the proto-
oncogene c-kit, which is involved in mast cell differen-
tiation, proliferation, survival and activation (London et al. 
1999). Specifically, the mutation of exon 11 of c-kit occurs 
in 30–50 % of advanced mast cell tumors and is similar 
to that usually occurring in 50–90 % of human gastroin-
testinal stromal tumors (Heinrich et al. 2002; London et al. 
2003). This evidence emphasizes a parallel between human 
and canine mast cell tumors underlying the possibility of 
using the canine model to develop new beneficial thera-
peutics for both species (Pryer et al. 2003). Non-Hodgkin 
lymphoma, which accounts for 5 % of all malignant tumors 
and 83 % of all hematopoietic malignancies in dogs (Vail 
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and Thamm 2004), affects mostly middle-aged, older 
dogs (German shepherds, boxers, basset hounds and Saint 
Bernards) (MacEwen and Young 1996) and both genders 
equally and corresponds to intermediate and high-grade 
non-Hodgkin lymphoma in humans. It is generally associ-
ated with a poor prognosis, and in 70–80 % of cases, it is 
B-cell mediated, whereas in 20–30 %, it is T-cell mediated 
(MacEwen 1995). Due to its sensitivity to chemotherapy, 
it is used as a model both for development of new chemo-
therapy drugs and multiple drug resistance studies (Vail 
and MacEwen 2000). Moreover, non-Hodgkin lymphoma 
has been used to develop hypoxic cell markers, study the 
whole-body hyperthermia effects and evaluate autologous 
bone transplantation (Vail and Thamm 2004).
Epidemiology of cancer in cats
Spontaneous osteosarcomas account for more than 70 % 
of malignant bone tumors in cats (Thompson and Pool 
2002; Brodey and Riser 1969). These tumors are relevant 
to human cancer biology, due to their relative resistance to 
chemotherapy (He et al. 2014) and widespread metastatic 
potential. Injection-site sarcomas in felines, usually fibro-
sarcomas, are caused by an intense inflammatory reac-
tion or vaccination adjuvants (Carwardine et al. 2013) and 
have extensively been reviewed (Hauck 2003). They are 
highly locally invasive and metastasize in up to 23 % of the 
affected cases (Seguin 2002). Although aggressive surgical 
resection remains the gold standard therapy, chemotherapy 
and radiation can prolong the survival times (Hershey et al. 
2000; Kobayashi et al. 2002). Uterine tumors, rare in cats, 
account for 0.29 % of feline neoplasms (Miller et al. 2003), 
and they include endometrial adenocarcinoma, mixed mul-
lerian tumor, leiomyoma which occurs most frequently 
(MacLachlan and Kennedy 2002) and myxoid leiomyosar-
coma (Cooper et al. 2006). Even if the etiology of nervous 
system tumors is not well understood, cats are commonly 
affected by meningiomas (Troxel et al. 2003). However, the 
biological behavior of such tumor, except for the anaplastic 
type, is generally considered benign in both humans (Louis 
et al. 2007) and common pets like dogs and cats (Motta 
et al. 2012). A pilot study evaluated the incidence of spon-
taneous tumors in cats living in the neighborhood of Ven-
ice and Vicenza (Vascellari et al. 2009). Four hundred and 
ninety-four out of 214,683 feline cases of neoplasia were 
diagnosed during the first three years. For all tumors, the 
estimated annual incidence rate in cats per 100,000 was 
77. Furthermore, a 4.6-fold higher incidence of malignant 
tumors was observed in cats, if compared to benign pathol-
ogy. Moreover, in pure breed cats, a twofold higher inci-
dence of malignant tumors was observed and it increased 
with age in both malignant and benign pathologies, if com-
pared with mixed breeds.
Translation of experimental studies into the clinical setting
In 2009, Wells introduced the potential role of pets in offer-
ing a therapeutic value to humans (Wells 2009b, 2012). 
Previous reports emphasized the role of dogs and cats as 
preventers of ill-health showing that pet owners are health-
ier than non-owners (Parslow et al. 2005; Wells 2009a; Wil-
son 1991; Serpell 1991; Allen et al. 2002; Anderson et al. 
1992; Baun et al. 1984; Dembicki and Anderson 1996; 
Friedmann et al. 1980; Katcher 1981; Katcher et al. 1983; 
Larson et al. 2010; Sebkova 1977; Siegel 1993; Vormbrock 
and Grossberg 1988). Furthermore, the ability of pets to 
facilitate human recovery has been explored (Larson et al. 
2010). For instance, Friedmann et al. reported that pet own-
ers were significantly more likely to be alive 1 year after a 
heart attack than non-owners (Friedmann et al. 1980) and 
dogs were stronger facilitators to recovery from ill-health 
than cats (Friedmann and Thomas 1995). Therefore, dogs 
may contribute indirectly to long-standing human physical 
health, which is of great importance, especially in immu-
nocompromised patients (Hemsworth and Pizer 2006), pos-
sibly due to the increased physical activity which typically 
characterizes the ownership of a dog (Larson et al. 2010). 
Dogs have also been used as warning systems for can-
cer (Williams and Pembroke 1989), epilepsy (Brown and 
Strong 2001; Dalziel et al. 2003; Strong et al. 1999, 2002) 
and diabetes (Chen et al. 2000; Lim et al. 1992; McAulay 
et al. 2001). They have also been used as therapists in nurs-
ing homes (Crowley-Robinson et al. 1996; Fick 1993; Kai-
ser et al. 2002), visitors in pediatric hospital wards (Moody 
et al. 2002), assistants for the disabled (Davis et al. 2004; 
Fishman 2003; Sanders 2000), enhancers of psychological 
welfare (Raina et al. 1999) and rehabilitators for prisoners 
(Merriam-Arduini 2000; Strimple 2003).
Discussion
Comparative oncology research has extensively relied on 
domestic animals (Antinoff and Hahn 2004; Hansen and 
Khanna 2004; Hershey et al. 2005; Nasir and Reid 1999; 
Seltenhammer et al. 2004; Withrow and Vail 2007). The 
Comparative Oncology Trials Consortium Program Infra-
structure, founded in 2009 to design and execute clinical 
trials involving dogs affected by cancer and in collabora-
tion with the drug manufacturing industry and nongov-
ernmental groups interested in cancer drug development, 
aimed to answer biological questions which could inform 
the development path of novel agents for future use in 
human cancer patients in a timely and integrated manner 
(Gordon et al. 2009). The recent identification of the canine 
genome has provided evidence of strong similarities with 
humans (Lindblad-Toh et al. 2005; O’Brien and Murphy 
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2003; Ostrander et al. 2006) such as several cancer-asso-
ciated gene families (Hoffman and Birney 2007), as well 
as the presence of the similar genetic cancer-associated 
molecular alterations (Haga et al. 2001; Setoguchi et al. 
2001; Thomas et al. 2003). Tumor initiation and progres-
sion are also influenced by age, nutrition, sex, reproduc-
tive status and environmental exposures in both human 
and canine cancers (Bukowski et al. 1998; Hayes and 
Fraumeni 1977; Misdorp 1996; Mukaratirwa 2005; Olson 
2007; Patronek et al. 1997). The lack of gold standards for 
the management of cancer in dogs and cats, as well as the 
high motivation of pet owners to seek out new options for 
its management, underlines the increasing need to evalu-
ate novel therapeutics in these populations. In this ways, it 
is possible to assess the effectiveness of new agents when 
given alone or in combination with other therapies prior to 
the clinical testing of the drug.
Conclusions
The enrollment of pet dogs in preclinical and clinical tri-
als is now focusing on new anti-neoplastic drug research 
and development. Although regulation of animal research 
possesses guidelines such as the three Rs (Replacement, 
Reduction and Refinement) (Russell and Burch 1959), legal 
implications regarding the use of animal models for research 
purposes are still debated (Griffin 1998; Porrello et al. 2004). 
Although the existence of spontaneous pet tumors could be 
a reliable model for human cancers, many open questions, 
related to the opportunities to select and recruit new types 
of animal models in oncology and to their legal and ethical 
implications, remain unanswered. Unfortunately, the use of 
spontaneous animal models implicates several professional 
and ethical warnings with conflictory debates. In the recent 
years, researchers have also focused their exploration on a 
possible role of some dog species as early warning sys-
tems for cancer (Williams and Pembroke 1989), epilepsy 
(Brown and Strong 2001; Dalziel et al. 2003; Strong et al. 
1999, 2002) and diabetes (Chen et al. 2000; Lim et al. 1992; 
McAulay et al. 2001). While some dogs have showed innate 
ability to recognize with smell the human cancers in vivo, 
others have been trained to perform this skill (Willis et al. 
2004). From this overview, there is evidence that companion 
animal health care is impressively growing in terms of devel-
opment of new therapies and diagnostic tools, nutrition and 
disease prevention (Kling 2007). Conclusively, we strongly 
encourage the animalists, veterinarians and clinical research-
ers to join us and support ethical observational studies on 
domestic and laboratory animal spontaneous cancer epide-
miology, early prevention, diagnosis and treatment in order 
to detect and possibly eliminate alimentary and environ-
mental factors which can also be cancerogenic for humans. 
In fact, the shorter life span of animals, compared with that 
of humans, can give a rapid overview of many clinical fea-
tures which also characterize human cancer. Furthermore, 
the pooling of anecdotal veterinary reports on drugs or mul-
timodal animal cancer treatments, protocols and outcomes, 
including surgical pathology, oncoimmunology and molecu-
lar biology investigations, will give outstanding contribution 
to the interspecies translational information with undoubted 
mutual interspecies benefit. The pet psychological and physi-
cal support to the fitness and wellness of cancer patients 
should be more deeply investigated and largely extended in 
the palliation practice.
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